Colossal Biosciences spins off Form Bio software, offers platform for advanced, AI-based applications
venturebeat.comSaved by Laura Pike Seeley
Colossal Biosciences spins off Form Bio software, offers platform for advanced, AI-based applications
#federatedlearning #drugdiscovery #structuralbiology #openfold3 | Robin Roehm | 18 comments
linkedin.com
How has pharma capitalized on the AI boom?
Partnerships.
The number pharma / AI partnerships over the past few years has exploded as awareness, access and proof-of-concept milestones have all accelerated. This has been driven both within biopharma (i.e. breakthroughs such as AlphaFold or the launch of... See more
We are proud to announce @periodiclabs. Our mission is to accelerate science.
Our founding team co-created ChatGPT, DeepMind’s GNoME, OpenAI’s Operator (now Agent), the neural attention mechanism, MatterGen; have scaled autonomous physics labs; and have contributed to important materials discoveries of the last... See more
Periodic Labsx.comAt first I didn't realize how big this was, until I read the fine print: TLDR with the insights baked in:
OpenAI has developed a novel language model called GPT-4b micro, specifically designed for protein engineering in collaboration with Retro Biosciences, a longevity research company backed by Sam Altman's $180... See more
David Shapiro ⏩x.com